June 20, 2019
PureTech Establishes New Corporate Headquarters in Boston’s Seaport District
PureTech will continue to leverage leadership in Brain-Immune-Gut axis biology to develop novel categories of therapeutics
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
June 20, 2019
Psoriasis Market and Forecast Analysis to 2025 – Otezla’s Favorable Safety Profile and Lower Cost Compared to Leading Anti-TNFs will Continue to Drive its Uptake
DUBLIN–(BUSINESS WIRE)–The “Psoriasis Market and Forecast Analysis to 2025” drug pipelines has been added to ResearchAndMarkets.com’s offering. Psoriasis is a…
June 20, 2019
Teva launches generic version of Tracleer tablets in the United States
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today
announced the launch of a generic version of Tracleer®1
(bosentan) tablets, 62.5 mg and 125 mg, in the U.S.
June 20, 2019
Zymeworks Announces Pricing of $175.0 Million Public Offering
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE/TSX:ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics (the “Company”), announced today the pricing of…
June 20, 2019
Prevail Therapeutics Announces Pricing of Initial Public Offering
Prevail Therapeutics Inc. (Nasdaq: PRVL) (Prevail), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative disorders, today announced the pricing of its initial public offering of 7,353,000 shares of its common stock at a price to the public of $17.00 per share.
June 20, 2019
Worldwide Immunotherapy Drugs Market Outlook 2019-2025: Massive Growth Opportunities in Both Developed & Developing Regions
DUBLIN–(BUSINESS WIRE)–The “Global Immunotherapy Drugs Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025” report has been added…
June 19, 2019
Glaukos Corporation Enters into Definitive Agreement to Acquire DOSE Medical Corporation
Glaukos will establish a new R&D retinal program that
complements our growing glaucoma franchise and pipeline.
June 19, 2019
Natural ingredients show beneficial effects on cardiovascular health and sports performance
Euromed, a Spain-based producer of standardized herbal extracts and natural active substances for pharmaceutical, nutraceutical and cosmetic industries, said Wednesday that, according to a recently published randomised, double-blind, placebo-controlled study, supplementation with Euromed’s natural extracts Pomanox™ and Mediteanox™ could help to maintain a healthy blood pressure, endothelial function and levels of circulating oxidised low-density lipoprotein cholesterol (oxLDL).
June 19, 2019
Lynparza approved in Japan for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
AstraZeneca and Merck revealed Wednesday that Lynparza (olaparib) has been approved in Japan as a maintenance treatment after 1st-line chemotherapy in patients with BRCA-mutated (BRCAm) advanced ovarian cancer, the only PARP inhibitor approved in Japan .
June 19, 2019
Boys and Girls Clubs of Canada Join the Fight Against the Opioid Crisis in National Partnership with Adapt Pharma Canada
Boys and Girls Clubs of Canada (BGCC) has partnered with NARCAN Nasal Spray manufacturers, Adapt Pharma Canada, in the continued fight against the devastating fallout of Canada’s opioid crisis.